Ying-Chung Hong

706 citations
20 papers · 534 indexed · h-index 10
Topics
Lymphoma Diagnosis and Treatment (8 papers)Multiple Myeloma Research and Treatments (4 papers)Chronic Lymphocytic Leukemia Research (3 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Ying-Chung Hong

20 papers receiving 527 citations

Peers

Ying-Chung Hong
Comparison fields: 5 of 60
  • Epidemiology 265
  • Hepatology 202
  • Oncology 134
  • Pathology and Forensic Medicine 131
  • Hematology 68
Replace Elisa Anselmi with:
Elisa Anselmi Italy
Carlo Moroni Italy
Hee Ho Chu South Korea
Luca Pezzullo Italy
Olga Trejo Spain
V. Rieu France
Yann Consigny France
Roberto Caprotti Italy
Jack Galliford United Kingdom
Kazuo Notsumata Japan
Ying-Chung Hong relative to Elisa Anselmi Italy Elisa Anselmi's profile →
Citations per field
00.5×3.2×
Elisa Anselmi · 1×
Citations per year

Countries citing papers authored by Ying-Chung Hong

Since Specialization
Citations

This map shows the geographic impact of Ying-Chung Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Chung Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Chung Hong more than expected).

Fields of papers citing papers by Ying-Chung Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying-Chung Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Chung Hong. The network helps show where Ying-Chung Hong may publish in the future.

Co-authorship network of co-authors of Ying-Chung Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Ying-Chung Hong. A scholar is included among the top collaborators of Ying-Chung Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying-Chung Hong. Ying-Chung Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 18
3 6
4 23
5 34
6 1
7 14
8 15
9 5
10 3
11 243
12 90
13 6
14 14
15 6
16 1
17 5
18 32
19 13
20 3

About Ying-Chung Hong

Ying-Chung Hong is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 20 papers that have together received 534 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hepatology (202 citations), Internal Medicine (49 citations) and Epidemiology (265 citations). Ying-Chung Hong has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Cheng‐Hwai Tzeng, Tzeon-Jye Chiou, Jyh-Pyng Gau, Liang-Tsai Hsiao, Chun‐Yu Liu, Yuan-Bin Yu, Yi‐Hsiang Huang, Pui-Ching Lee, Muh‐Hwa Yang and Shou‐Dong Lee. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026